Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity
暂无分享,去创建一个
D. Heckerman | E. Rosenberg | H. Jessen | B. Walker | M. John | S. Mallal | P. Harrigan | À. Olvera | C. Brander | M. Markowitz | N. Frahm | J. Carlson | A. Kelleher | Z. Brumme | C. Brumme | P. Cheung | M. Brockman | Joaquín Sánchez | A. Le | R. McGovern | D. Chopera | J. Sela | Tristan J. Markle | E. Martin
[1] Todd M. Allen,et al. Definition of the viral targets of protective HIV-1-specific T cell responses , 2011, Journal of Translational Medicine.
[2] D. Heckerman,et al. Translation of HLA–HIV Associations to the Cellular Level: HIV Adapts To Inflate CD8 T Cell Responses against Nef and HLA-Adapted Variant Epitopes , 2011, The Journal of Immunology.
[3] R. Siliciano,et al. Viral suppression of multiple escape mutants by de novo CD8+ T cell responses in a human immunodeficiency virus-1 Infected elite suppressor , 2011, Retrovirology.
[4] E. Arts,et al. HIV-1 replicative fitness in elite controllers , 2011, Current opinion in HIV and AIDS.
[5] M. Churchill,et al. The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control , 2011, Current opinion in HIV and AIDS.
[6] Sebastian Bonhoeffer,et al. A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase , 2011, Nature Genetics.
[7] David Heckerman,et al. Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations , 2011, PloS one.
[8] P. Cherepanov,et al. Structural insights into the retroviral DNA integration apparatus. , 2011, Current opinion in structural biology.
[9] A. Engelman,et al. Structural biology of retroviral DNA integration. , 2011, Virology.
[10] D. Hazuda,et al. Raltegravir: the first HIV‐1 integrase strand transfer inhibitor in the HIV armamentarium , 2011, Annals of the New York Academy of Sciences.
[11] Todd M. Allen,et al. Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase–Integrase Sequences From HIV-1 Elite Controllers , 2011, Journal of acquired immune deficiency syndromes.
[12] W. Powderly. Integrase inhibitors in the treatment of HIV-1 infection. , 2010, The Journal of antimicrobial chemotherapy.
[13] Goedele N. Maertens,et al. The mechanism of retroviral integration through X-ray structures of its key intermediates , 2010, Nature.
[14] D. Kuritzkes,et al. Effect of Raltegravir Resistance Mutations in HIV-1 Integrase on Viral Fitness , 2010, Journal of acquired immune deficiency syndromes.
[15] Todd M. Allen,et al. Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection , 2010, Journal of Virology.
[16] David Heckerman,et al. Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.
[17] S. Buus,et al. Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.
[18] E. Rosenberg,et al. Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers , 2010, Journal of Virology.
[19] P. Goulder,et al. Long-Term Control of HIV-1 in Hemophiliacs Carrying Slow-Progressing Allele HLA-B*5101 , 2010, Journal of Virology.
[20] B. Clotet,et al. The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates , 2010, AIDS.
[21] David W. Haas,et al. HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins , 2009, PloS one.
[22] Anthony D. Kelleher,et al. Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells , 2009, Journal of Virology.
[23] Eric J. Arts,et al. Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.
[24] M. Essex,et al. Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.
[25] Todd M. Allen,et al. HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.
[26] Philip J. R. Goulder,et al. Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein , 2008, Journal of Virology.
[27] Tommy F. Liu,et al. Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors , 2008, Retrovirology.
[28] David Heckerman,et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.
[29] David Heckerman,et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.
[30] Tanmoy Bhattacharya,et al. HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load , 2008, Journal of Virology.
[31] Winston A Hide,et al. Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.
[32] S. Oka,et al. CTL-Mediated Selective Pressure Influences Dynamic Evolution and Pathogenic Functions of HIV-1 Nef1 , 2008, The Journal of Immunology.
[33] M. Quiñones-Mateu,et al. Viral drug resistance and fitness. , 2008, Advances in pharmacology.
[34] Todd M. Allen,et al. Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.
[35] Nebojsa Jojic,et al. Extensive HLA class I allele promiscuity among viral CTL epitopes , 2007, European journal of immunology.
[36] Todd M. Allen,et al. Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A , 2007, Journal of Virology.
[37] David Heckerman,et al. Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 , 2007, PLoS pathogens.
[38] P. Harrigan,et al. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy. , 2007, The Journal of infectious diseases.
[39] D. Heckerman,et al. Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.
[40] C. Boutwell,et al. Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. , 2007, AIDS research and human retroviruses.
[41] F. Pereyra,et al. Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes , 2007, Journal of Virology.
[42] David Heckerman,et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.
[43] David C. Nickle,et al. Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection , 2006, Journal of Virology.
[44] Todd M. Allen,et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.
[45] B. Walker,et al. The challenges of host and viral diversity in HIV vaccine design. , 2006, Current opinion in immunology.
[46] David Heckerman,et al. Leveraging Information Across HLA Alleles/Supertypes Improves Epitope Prediction , 2006, RECOMB.
[47] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[48] Todd M. Allen,et al. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. , 2006, Journal of virological methods.
[49] Christian Brander,et al. Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.
[50] D. Heckerman,et al. Leveraging Information Across HLA Alleles/Supertypes Improves HLA-Specific Epitope Prediction , 2005 .
[51] O. Lund,et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.
[52] R. Hogg,et al. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. , 2004, International journal of epidemiology.
[53] Norman L. Letvin,et al. Fitness Costs Limit Viral Escape from Cytotoxic T Lymphocytes at a Structurally Constrained Epitope , 2004, Journal of Virology.
[54] E. Rosenberg,et al. CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects , 2004, Journal of Translational Medicine.
[55] F. M. Marincola,et al. Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities , 2004, Journal of Virology.
[56] John Sidney,et al. Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.
[57] Mark A Wainburg. The impact of the M184V substitution on drug resistance and viral fitness , 2004 .
[58] M. Wainberg. The impact of the M184V substitution on drug resistance and viral fitness. , 2004, Expert review of anti-infective therapy.
[59] O. Gascuel,et al. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. , 2003, Systematic biology.
[60] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[61] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. Sudoł,et al. An Amino Acid in the Central Catalytic Domain of Three Retroviral Integrases That Affects Target Site Selection in Nonviral DNA , 2003, Journal of Virology.
[63] Søren Brunak,et al. Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.
[64] Wei Yang,et al. Structure of a two‐domain fragment of HIV‐1 integrase: implications for domain organization in the intact protein , 2001, The EMBO journal.
[65] R M Stroud,et al. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] S. Oka,et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. , 1999, Human immunology.
[67] G A Satten,et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.
[68] J. Zhang,et al. Methods for comparing a DNA sequence with a protein sequence , 1996, Comput. Appl. Biosci..